Neuehealth Inc (NEUE) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access NEUE Annual Cash Flow →
A period-by-period view of cash flow from Neuehealth Inc to Jun 30 2024 helps clarify how Jun 30 2025's cash position has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2025)
6 Months
(Mar 31 2025) (Dec 31 2024) (Sep 30 2024) (Jun 30 2024)
Operating Activities
Income-12.40
Depreciation & amortization7.11
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.09
Share-based Compensation7.50
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest8.95
Equity Securities Fv Ni Unrealized Gain Loss-
Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve-31.42
Increase Decrease In Direct Contracting Performance Year Receivable-226.52
Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest-
Impairment Of Intangible Assets Excluding Goodwill-
Impairment Of Intangible Assets Excluding Goodwill Including Discontinued Operations And Disposal Groups-
Gains Losses On Restructuring Of Debt-
Increase Decrease In Warrant Liability-2.09
Increase Decrease In Risk Share Payable Deconsolidated Entity-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-16.48
Increase (Decrease) in Accounts Payable and Other Operating Liabilities-12.48
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital9.57
Other Noncash Income (Expense)1.03
Other net0.00
Payments for (Proceeds from) Other Operating Activities243.27
Discontinued operations0.00
Net Cash flow from Operating Activities-23.88
Investing Activities
Capital Expenditures-2.65
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments-3.84
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses, Net of Cash Divested61.14
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities54.65
Financing Activities
Short-term debt Net-1.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock-2.25
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Distribution To Noncontrolling Interest Holders-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-3.25
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-26.53
Total Cash Flow27.53
4 historic quarters locked

Sign in to unlock the full Neuehealth Inc cash flow history.

About Neuehealth Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20250630)
  • Filed with the SEC: August 7, 2025
  • Source: bhg-20250630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-25-038856

Figures are derived from filed reports and may be restated. Historical data is subject to revision.